Maelicke A[au] - Search Results

Year	Number of Results
1971	2
1972	3
1973	1
1974	3
1975	2
1976	1
1977	1
1978	2
1979	1
1980	4
1981	4
1982	2
1983	7
1984	4
1986	2
1987	2
1988	3
1989	6
1990	2
1991	9
1992	7
1993	6
1994	7
1995	6
1996	10
1997	9
1998	8
1999	5
2000	8
2001	7
2002	4
2003	2
2004	4
2005	1
2006	1
2007	1
2008	1
2009	3
2010	3
2014	1
2015	1
2016	1
2022	0

1

Maelicke A. Maelicke A. Trends Biochem Sci. 1991 Oct;16(10):355-6. doi: 10.1016/0968-0004(91)90146-m. Trends Biochem Sci. 1991. PMID: 1785133 Review. No abstract available.

2

Recent results of tRNA research.

Gauss DH, von der Haar F, Maelicke A, Cramer F. Gauss DH, et al. Among authors: maelicke a. Annu Rev Biochem. 1971;40:1045-78. doi: 10.1146/annurev.bi.40.070171.005145. Annu Rev Biochem. 1971. PMID: 4941233 Review. No abstract available.

3

[New theory! Galantamine and nicotinic-cholinergic transmission].

Maelicke A, Weichel C. Maelicke A, et al. Pharm Unserer Zeit. 2002;31(4):390-3. doi: 10.1002/1615-1003(200207)31:4<390::AID-PAUZ390>3.0.CO;2-6. Pharm Unserer Zeit. 2002. PMID: 12162069 Review. German. No abstract available.

4

Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor alpha-polypeptide.

Schröder B, Reinhardt-Maelicke S, Schrattenholz A, McLane KE, Kretschmer A, Conti-Tronconi BM, Maelicke A. Schröder B, et al. Among authors: maelicke a. J Biol Chem. 1994 Apr 8;269(14):10407-16. J Biol Chem. 1994. PMID: 8144624 Free article.

5

Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.

Maelicke A. Maelicke A. Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:11-8. doi: 10.1159/000051227. Dement Geriatr Cogn Disord. 2000. PMID: 10971047 Review.

6

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease.

Maelicke A, Schrattenholz A, Samochocki M, Radina M, Albuquerque EX. Maelicke A, et al. Behav Brain Res. 2000 Aug;113(1-2):199-206. doi: 10.1016/s0166-4328(00)00214-x. Behav Brain Res. 2000. PMID: 10942046 Review.

7

Cell fate specification in an in vitro model of neural development.

Jostock R, Rentrop M, Maelicke A. Jostock R, et al. Among authors: maelicke a. Eur J Cell Biol. 1998 May;76(1):63-76. doi: 10.1016/S0171-9335(98)80018-6. Eur J Cell Biol. 1998. PMID: 9650784

8

Nicotinic receptor function in the mammalian central nervous system.

Albuquerque EX, Pereira EF, Castro NG, Alkondon M, Reinhardt S, Schröder H, Maelicke A. Albuquerque EX, et al. Among authors: maelicke a. Ann N Y Acad Sci. 1995 May 10;757:48-72. doi: 10.1111/j.1749-6632.1995.tb17464.x. Ann N Y Acad Sci. 1995. PMID: 7611705 Review.

9

Unconventional ligands and modulators of nicotinic receptors.

Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX. Pereira EF, et al. Among authors: maelicke a. J Neurobiol. 2002 Dec;53(4):479-500. doi: 10.1002/neu.10146. J Neurobiol. 2002. PMID: 12436414 Review.

10

Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity.

Albuquerque EX, Pereira EF, Alkondon M, Schrattenholz A, Maelicke A. Albuquerque EX, et al. Among authors: maelicke a. J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):243-66. doi: 10.3109/10799899709036607. J Recept Signal Transduct Res. 1997. PMID: 9029494 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results